Furthermore, the lack of device-aided approaches in our cohort might also be compatible with relatively low doses of L-Dopa overall and the relatively benign nature of PRKN- or PINK1-related PD even in terms of motor symptoms. The gene discussed is PINK1; the disease is Parkinson disease.